Hcv core lipid binding domain monoclonal antibodies
AssigneeAbbott Laboratories
InventorsRobert Ziemann, April Ahlberg, David Hawksworth, Bryan Tieman, A. Scott Muerhoff, Christopher Marohnic, Kathy Otis
Life of this patent
Estimating the term…
Abstract
The present invention relates to monoclonal antibodies for the detection of HCV antigen. More specifically, the invention describes antibodies against HCV core antigen lipid binding domain and immunoassay methods, kits and compositions for use in detecting HCV infection.
Claims20
A monoclonal antibody that is specifically immunoreactive with the lipid binding domain of HCV core antigen.
A monoclonal antibody that is specifically immunoreactive with the lipid binding domain of HCV core antigen, wherein said monoclonal antibody has a heavy chain variable domain selected from the group consisting of the antibodies listed in Table 1A, and a light chain variable domain selected from the group consisting of the antibodies listed in Table 1B.
Dependencies are inferred from the claim text.